International Academy of Cardiology Annual Scientific Sessions 2020 - 25th World Congress on Heart Disease

  • 24-26 Jul 2020

Description

The International Academy of Cardiology Annual Scientific Sessions 2020 - 25th World Congress on Heart Disease covers topics such as:

  • DIAGNOSTIC METHODS
    • Transesophageal echocardiography
    • Biochemical markers of acute ischemia
    • Echocardiography, three-dimensional reconstruction
    • Pharmacologic stress testing - echocardiography
    • PET - new insights into myocardial metabolism
    • Nuclear cardiology - new techniques to assess cardiac perfusion, function and viability
    • CT and coronary calcification
    • Applications of cardiac magnetic resonance imaging
    • Intravascular ultrasound imaging
    • Percutaneous coronary angioscopy
    • Intracoronary flow, doppler measurements
  • MOLECULAR CARDIOLOGY, BASIC RESEARCH
    • Oxidative stress and anti-oxidant therapy
    • Apoptosis in vascular and cardiac remodeling
    • Genetic studies in cardiomyopathy
    • Genetic determinants of coronary heart disease
    • The pathogenesis of atherosclerosis
    • Gene transfer and therapy
    • Immunological principles in coronary artery disease
    • Extracellular matrix and atherosclerosis
    • Neointimal hyperplasia and vascular injury
    • Growth control and cytokines in vascular cells
    • Pharmacologic modulation of vascular-endothelial function
  • HEART FAILURE
    • Nitric oxide and nitric oxide synthase in heart failure
    • Neurohumoral, immunologic and cytokine aspects of heart failure
    • Natriuretic peptides, endothelin: role in heart failure
    • Myocyte and receptor abnormalities in heart failure
    • Dilated cardiomyopathy: various etiologies
    • Inflammatory mediators and heart failure
    • Left ventricular hypertrophy and hypertrophic cardiomyopathy
    • Ischemic cardiomyopathy
    • Pathophysiologic and prognostic insights in valvular heart disease
    • Role of the pericardium, pericarditis and restrictive cardiomyopathy
    • Predictors and markers of heart failure outcome
    • Pulmonary circulation aspects, pulmonary hypertension
    • Renal aspects - diuretics
    • Exercise physiology in heart failure
    • ACE inhibitors and Angiotensin-ll receptor blockers
    • Digoxin and other new inotropic agents in heart failure
    • Calcium channel blockers and promoters in heart failure
    • Beta-blockers and beta-adrenergic receptors in heart failure
    • Cardiac pacing strategies in heart failure
  • CORONARY ARTERY DISEASE
    • Mechanisms involved in myocardial stunning, hibernation and ischemic preconditioning
    • The plaque and acute coronary syndromes
    • Angioplasty therapy for acute myocardial infarction
    • Acute myocardial infarction: thrombolysis and reperfusion
    • Antithrombotic and antiplatelet adjunctive therapy for PTCA
    • Stents: new devices/optimal application/multiple stents
    • Restenosis - use of ionizing radiation
    • Blockade of tissue proliferation after coronary interventions
    • Left ventricular remodeling after myocardial infarction
    • Nitrates, beta blockers, calcium entry blockers and ACE inhibition for myocardial ischemia/infarction
    • Secondary prevention, risk stratification
    • Assessment of prognosis, post acute myocardial infarction
    • Can the progress of atherosclerosis be halted?
    • Cardiac rehabilitation as secondary prevention: is it worth the effort?
    • Hypertension, new therapeutic approaches
    • Modification of lipoproteins and coronary disease
    • Mental stress: its effect on cardiovascular health
    • Diabetes mellitus, obesity, insulin and atherosclerosis
    • Hormone therapy in postmenopausal women: does it alter coronary risk?
    • Primary prevention of coronary artery disease in the healthy adult
    • Prevention in children
  • CARDIAC SURGERY
    • Angioplasty or surgery for multivessel coronary artery disease
    • Advances in congenital heart disease
    • Therapeutic and physiologic issues surrounding heart valve surgery
    • New approaches to surgical revascularization: Minimally invasive surgery, TMLR
    • Surgery for LV dysfunction
    • Mechanical support left ventricular assist devices
    • Cardiac transplantation
  • ARRHYTHMIAS
    • Atrial flutter/fibrillation - electrophysiologic concepts and clinical aspects
    • Arrhythmias and antiarrhythmic drug therapy
    • Heart rate variability and prognostic implications
    • Management of cardiac arrhythmias pediatric population
    • Sudden death
    • QT prolongation/dispersion: pathophysiology and prognostic implications
    • Advances in internal defibrillation and implantable antiarrhythmic devices
    • Electrophysiologic techniques of mapping and radiofrequency ablation
    • Cardiac Pacing
  • MISCELLANEOUS
    • Computers in cardiology
    • Practice guidelines, cost containment

The International Academy of Cardiology Annual Scientific Sessions 2020 - 25th World Congress on Heart Disease will be held in United States on 24-26 Jul 2020.

Venue

Boston,
,
United States
View Hotels near Venue
Free cancellation available

More Details

Prices:
485-795 US Dollar   (Early registration date: 09 Apr 2020)
Exhibition:
Included
Organizer:
International Academy of Cardiology (Cardioligy Online)
Website:

Future Events

  • International Academy of Cardiology Annual Scientific Sessions 2020 - 25th World Congress on Heart Disease - 24-26 Jul 2020, United States (32688)
  • International Academy of Cardiology Annual Scientific Sessions 2021 - 26th World Congress on Heart Disease - Jul 2021, Vancouver, Canada (22130)

Past Events

  • International Academy of Cardiology Annual Scientific Sessions 2019 - 24th World Congress on Heart Disease - 26-28 Jul 2019, Hyatt Regency Vancouver, Vancouver, Canada (22131)

Important

Please, check the official conference website for possible changes, before you make any traveling arrangements

Prices are for evaluation only.

Featured Conferences & Exhibitions